- Home
- NKTX vs STRW Comparison
NKTX vs STRW Comparison
Compare NKTX & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- STRW
- Stock Information
- Founded
- NKTX 2015
- STRW 2015
- Country
- NKTX United States
- STRW United States
- Employees
- NKTX N/A
- STRW N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- STRW Real Estate Investment Trusts
- Sector
- NKTX Health Care
- STRW Real Estate
- Exchange
- NKTX Nasdaq
- STRW Nasdaq
- Market Cap
- NKTX 123.5M
- STRW 133.6M
- IPO Year
- NKTX 2020
- STRW N/A
- Fundamental
- Price
- NKTX $1.74
- STRW $10.20
- Analyst Decision
- NKTX Strong Buy
- STRW Strong Buy
- Analyst Count
- NKTX 6
- STRW 4
- Target Price
- NKTX $14.80
- STRW $13.83
- AVG Volume (30 Days)
- NKTX 422.6K
- STRW 50.7K
- Earning Date
- NKTX 05-14-2025
- STRW 05-09-2025
- Dividend Yield
- NKTX N/A
- STRW 5.49%
- EPS Growth
- NKTX N/A
- STRW 34.22
- EPS
- NKTX N/A
- STRW 0.58
- Revenue
- NKTX N/A
- STRW $126,557,000.00
- Revenue This Year
- NKTX N/A
- STRW $15.21
- Revenue Next Year
- NKTX N/A
- STRW $2.21
- P/E Ratio
- NKTX N/A
- STRW $17.69
- Revenue Growth
- NKTX N/A
- STRW 22.41
- 52 Week Low
- NKTX $1.31
- STRW $8.70
- 52 Week High
- NKTX $8.23
- STRW $12.90
- Technical
- Relative Strength Index (RSI)
- NKTX 45.11
- STRW 46.67
- Support Level
- NKTX $1.70
- STRW $9.46
- Resistance Level
- NKTX $1.82
- STRW $10.75
- Average True Range (ATR)
- NKTX 0.10
- STRW 0.66
- MACD
- NKTX -0.01
- STRW 0.03
- Stochastic Oscillator
- NKTX 18.82
- STRW 50.79
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.